Evotec launches 'PRROTECT', pre-competitive initiative to be better prepared for future pandemics

  . INTEGRATED PLATFORM APPROACH TO RESPOND TO THE CHALLENGES OF PANDEMIC PREPAREDNESS, RAPID RESPONSE AND

    DELIVERABILITY 
  . PRROTECT COMBINES FIRST-IN-CLASS PROGRAMMES ACROSS THERAPEUTIC MODALITIES, ACCELERATED R&D TIMELINES FOR HIGHLY 
    EFFECTIVE NEUTRALISING ANTIBODIES WITH AI/ML PREDICTION TOOLS (J.HAL^?) AND MANUFACTURING PLATFORM (J.POD^(R)) 
 
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that the Company has 
launched an initiative for pandemic preparedness ("PRROTECT"). PRROTECT leverages a comprehensive set of novel projects 
and technologies to be better prepared for and respond faster to viral pandemics of the future. 
Virus outbreaks that can develop into dynamic pandemics are a permanent global threat. Besides preventive measures and 
vaccines, highly effective therapeutics are the backbone of any pandemic response. Evotec's PRROTECT initiative 
includes the development and delivery of superior novel therapeutics to curb the next viral pandemic. Based on the 
Company's distinctive set of global capabilities, Evotec is uniquely positioned to develop next-generation therapeutics 
across all modalities including small molecules, protein degraders, antibodies and immuno-modulators, but excluding 
vaccines. 
PRROTECT will be an open pre-competitive network initiative designed to offer the best protection against future 
pandemics by including three lines of preparation: 
  . Preparedness against viral threats, i.e. the pre-development of a multimodality pipeline of therapeutic candidates 
    against the most threatening viruses as defined by the World Health Organisation ("WHO") 
  . Rapid response technologies to accelerate de novo R&D timelines of highly effective neutralising antibodies using 
    AI & ML platforms (e.g. J.HAL^?) 
  . Flexible manufacturing network with highly intensified production facilities (J.POD^(R)) to provide therapeutic 
    antibodies quickly wherever needed 

https://www.marketscreener.com/quote/stock/EVOTEC-SE-436047/news/PRESS-RELEASE-nbsp-Evotec-launches-PRROTECT-a-pre-competitive-initiative-to-be-better-prepared-35605232/